Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.022 AUD
−20.92 M AUD
0.00 AUD
1.58 B
About SYNTARA LIMITED
Sector
CEO
Gary Jonathan Phillips
Headquarters
Sydney
Website
Founded
1998
ISIN
AU0000312480
FIGI
BBG000BTN0H9
Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SNT is 0.060 AUD — it has decreased by −6.25% in the past 24 hours. Watch SYNTARA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange SYNTARA LIMITED stocks are traded under the ticker SNT.
SNT stock has fallen by −9.09% compared to the previous week, the month change is a 33.33% rise, over the last year SYNTARA LIMITED has showed a 130.77% increase.
We've gathered analysts' opinions on SYNTARA LIMITED future price: according to them, SNT price has a max estimate of 0.20 AUD and a min estimate of 0.12 AUD. Watch SNT chart and read a more detailed SYNTARA LIMITED stock forecast: see what analysts think of SYNTARA LIMITED and suggest that you do with its stocks.
SNT stock is 6.67% volatile and has beta coefficient of 4.08. Track SYNTARA LIMITED stock price on the chart and check out the list of the most volatile stocks — is SYNTARA LIMITED there?
Today SYNTARA LIMITED has the market capitalization of 94.75 M, it has increased by 2.99% over the last week.
Yes, you can track SYNTARA LIMITED financials in yearly and quarterly reports right on TradingView.
SYNTARA LIMITED is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
SNT net income for the last half-year is −14.97 M AUD, while the previous report showed −5.95 M AUD of net income which accounts for −151.69% change. Track more SYNTARA LIMITED financial stats to get the full picture.
No, SNT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTARA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNTARA LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNTARA LIMITED stock shows the buy signal. See more of SYNTARA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.